 Propranolol
"Propranolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
| Descriptor ID |
D011433
|
| MeSH Number(s) |
D02.033.100.624.698.711 D02.033.755.624.698.711 D02.092.063.624.698.711 D02.455.426.559.847.638.945 D04.615.638.945
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Propranolol".
Below are MeSH descriptors whose meaning is more specific than "Propranolol".
This graph shows the total number of publications written about "Propranolol" by people in this website by year, and whether "Propranolol" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 | | 1998 | 0 | 1 | 1 | | 2000 | 1 | 0 | 1 | | 2001 | 0 | 4 | 4 | | 2002 | 0 | 1 | 1 | | 2004 | 2 | 0 | 2 | | 2005 | 0 | 1 | 1 | | 2007 | 1 | 2 | 3 | | 2008 | 0 | 1 | 1 | | 2010 | 1 | 0 | 1 | | 2011 | 1 | 1 | 2 | | 2013 | 1 | 0 | 1 | | 2014 | 2 | 0 | 2 | | 2015 | 0 | 1 | 1 | | 2016 | 1 | 0 | 1 | | 2018 | 0 | 1 | 1 | | 2019 | 1 | 0 | 1 | | 2020 | 2 | 1 | 3 | | 2026 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Propranolol" by people in Profiles.
-
Daley MF, Rifas-Shiman SL, Young JG, Petimar J, Prentice C, Bailey LC, Janicke DM, Heerman WJ, Block JP. Effects of Common Antihypertensive Class Medications on BMI z-Score in Adolescents. Pediatr Obes. 2026 May; 21(5):e70114.
-
Braun M, Metry D, Frieden IJ, Antaya RJ, Mancini AJ, Kohn LL. Persistent dysesthesias in involuted infantile hemangiomas: An uncommon complication in a common condition. Pediatr Dermatol. 2021 Sep; 38(5):1061-1065.
-
Gandhi S, Pandey MR, Attwood K, Ji W, Witkiewicz AK, Knudsen ES, Allen C, Tario JD, Wallace PK, Cedeno CD, Levis M, Stack S, Funchain P, Drabick JJ, Bucsek MJ, Puzanov I, Mohammadpour H, Repasky EA, Ernstoff MS. Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity. Clin Cancer Res. 2021 01 01; 27(1):87-95.
-
Brady SL, Wong KK, Doubrovin M, Han Y, Li Y, Wu S, Hossain AKMM, Chism CB, Naik MH, Rossi M, Shulkin BL. Effect of Propranolol on 18F-Fluorodeoxyglucose Uptake in Brown Adipose Tissue in Children and Young Adults with Neoplastic Diseases. Mol Imaging Biol. 2021 04; 23(2):260-269.
-
Liao P, Song K, Zhu Z, Liu Z, Zhang W, Li W, Hu J, Hu Q, Chen C, Chen B, McLeod HL, Pei H, Chen L, He Y. Propranolol Suppresses the Growth of Colorectal Cancer Through Simultaneously Activating Autologous CD8+ T Cells and Inhibiting Tumor AKT/MAPK Pathway. Clin Pharmacol Ther. 2020 09; 108(3):606-615.
-
Park BD, Lyn-Kew K, Granchelli A, Mehta A. A 62-Year-Old Woman With Diffuse Myalgias, Fatigue, and Shortness of Breath. Chest. 2020 03; 157(3):e75-e78.
-
Droho S, Cuda CM, Perlman H, Lavine JA. Monocyte-Derived Macrophages Are Necessary for Beta-Adrenergic Receptor-Driven Choroidal Neovascularization Inhibition. Invest Ophthalmol Vis Sci. 2019 12 02; 60(15):5059-5069.
-
Silverman E, Haber LA, Geha RM. Lift Then Shift: Thyrotoxic Periodic Paralysis. Am J Med. 2019 01; 132(1):e3-e6.
-
Levin MD, Saitta SC, Gripp KW, Wenger TL, Ganesh J, Kalish JM, Epstein MR, Smith R, Czosek RJ, Ware SM, Goldenberg P, Myers A, Chatfield KC, Gillespie MJ, Zackai EH, Lin AE. Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients. Am J Med Genet A. 2018 08; 176(8):1711-1722.
-
Brown DA, Gibbons J, Honari S, Klein MB, Pham TN, Gibran NS. Propranolol Dosing Practices in Adult Burn Patients: Implications for Safety and Efficacy. J Burn Care Res. 2016 May-Jun; 37(3):e218-26.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|